Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00032058 · ClinicalTrials.gov registry record · NA

Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer

A NA study of Prostate Cancer, sponsored by American College of Radiology Imaging Network.

Completed
Registry status
NA
Development phase
8
Study locations

NCT00032058: Completed NA study of Prostate Cancer, sponsored by American College of Radiology Imaging Network.

NCT00032058 is a NA study of Prostate Cancer that has completed, run by American College of Radiology Imaging Network. The trial reports 8 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00032058, a NA study of Prostate Cancer, has completed, sponsored by American College of Radiology Imaging Network.

COMPLETED
Registry status
NA
Development phase
8
Study locations

Study Summary

RATIONALE: Imaging procedures such as magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) may improve the ability to detect the extent of prostate cancer. It is not yet known if MRI combined with MRSI is more effective than MRI alone in detecting the extent of prostate cancer. PURPOSE: Diagnostic trial to compare the effectiveness of combining MRI with MRSI to that of MRI alone in determining the extent of prostate cancer in patients who are scheduled to undergo surgery to remove the prostate gland.

Conditions Studied

Prostate Cancer

Interventions

  • PROCEDURE magnetic resonance spectroscopic imaging
  • PROCEDURE magnetic resonance imaging

Study Locations (8)

California

  • UCSF Comprehensive Cancer Center - San Francisco

Connecticut

  • Yale Comprehensive Cancer Center - New Haven

Maryland

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins - Baltimore

Massachusetts

  • Brigham and Women's Hospital - Boston

Minnesota

  • Mayo Clinic Cancer Center - Rochester

New York

  • Memorial Sloan-Kettering Cancer Center - New York

Pennsylvania

  • Abramson Cancer Center of the University of Pennsylvania - Philadelphia

Texas

  • M.D. Anderson Cancer Center at University of Texas - Houston

Trial Details

FieldValue
Start Date 2003-06
Phase NA
American College of Radiology Imaging Network

14 total trials

What the finished NCT00032058 record still lists

NCT00032058 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which magnetic resonance spectroscopic imaging is the first listed.

NCT00032058 lists 8 locations in 8 states (California, Connecticut, Maryland).

Frequently Asked Questions

What is clinical trial NCT00032058 about?

NCT00032058 is a clinical study titled "Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer". RATIONALE: Imaging procedures such as magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) may improve the ability to detect the extent of prostate cancer. It is not yet known if MRI combined with MRSI is more effective than MRI alone in detecting the extent of prosta...

What is the current status of trial NCT00032058?

This trial is currently completed. It is a NA study. The study started on 2003-06.

What conditions does trial NCT00032058 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT00032058?

The interventions under investigation include: magnetic resonance spectroscopic imaging (PROCEDURE), magnetic resonance imaging (PROCEDURE).

Who is sponsoring clinical trial NCT00032058?

This trial is sponsored by American College of Radiology Imaging Network, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00032058 being conducted?

This trial has 8 study locations across California, Connecticut, Maryland, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00032058, the US trial registry maintained by the National Library of Medicine. NCT00032058 (unsized enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.